| Structure | Chemical Name | CAS | MF |
|
(2S)-2-[[(4S)-5-Cyclohexyl-2,2-difluoro-4-[[(8-isobutyl-6-phenyl-1,2,4-triazolo[4,3-a]pyrazin-3-yl)acetyl]amino]-3-oxopentanoyl]amino]-4-methyl-N-(2-pyrimidinylmethyl)valeramide
|
|
C39H49F2N9O4
|
|
[1S,2S,(-)]-1,2-Cyclohexanedimethanol
|
3205-34-3
|
C8H16O2
|
|
(4S,5S)-6-Cyclohexyl-5-[[(2R,4R,5S)-6-phenyl-5-(benzyloxycarbonylamino)-4-hydroxy-2-pentylhexanoyl]amino]-4-hydroxy-2-methylene-N-(2-methylpropyl)hexanamide
|
|
C42H63N3O6
|
|
(4S,5S)-6-Cyclohexyl-5-[2-[[(2S)-2-(benzyloxycarbonylamino)-3-phenylpropionyl]amino]-6-heptenoylamino]-4-hydroxy-2-methylene-N-(2-methylpropyl)hexanamide
|
|
C41H58N4O6
|
|
(1S,2S)-2-CYCLOPROPYLAMINO CYCLOHEXANOL
|
189362-39-8
|
C9H17NO
|
|
(S,S)-5-CYCLOOCTENE-1,2-DIOL
|
69926-50-7
|
C8H14O2
|
|
(1S,4S)-2-CYCLOPENTYLMETHYL-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE
|
1354350-20-1
|
C11H20N2
|
|
(1S,4S)-(+)-2-CYCLOPENTYLMETHYL-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE DIHYDROCHLORIDE
|
845866-64-0
|
C11H20N2
|
|
(1S,2S)-(-)-[1,2-CYCLOHEXANEDIAMINO-N,N'-BIS(3,5-DI-T-BUTYLSALICYLIDENE)]CHROMIUM(III)CHLORIDE
|
219143-92-7
|
C36H52ClCrN2O2
|
|
(S,S)-(+)-1,2-CYCLODODECANEDIOL
|
118101-31-8
|
C12H24O2
|
|
(1S,2S)-(+)-[1,2-CYCLOHEXANEDIAMINO-N N'-BIS(3,5-DI-T-BUTYLSALICYLIDENE)]ALUMINUM (III) CHLORIDE
|
207234-63-7
|
C36H52AlClN2O2
|
|
(4S,5S,αE,α'E)-2,2-Dimethyl-1,3-dioxolane-4,5-bis(acrylic acid methyl) ester
|
|
|
|
(3S,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid
|
688735-41-3
|
C25H24FNO4
|
|
|
(1S,1'S)-4,4'-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonene-1,18-diyl]bis(2-oxo-3,5,5-trimethyl-3-cyclopentene-1-carboxylic acid)
|
|
|
|
|
(6S,7S,10E,14E,18E)-6,7-Epoxy-2,6,10,15,19,23-hexamethyl-2,10,14,18,22-tetracosapentene
|
|
|
|
5-[(2S,6S,7E,9E)-13-(3-Furyl)-2,6,10-trimethyl-7,9-tridecadienylidene]-4-hydroxy-3-methylfuran-2(5H)-one
|
37905-12-7
|
C25H34O4
|
|
|
(1S,2S,3E,7E)-2-Hydroxy-4,8,12-trimethyl-β-methylenecyclotetradeca-3,7,11-triene-1-ethanol
|
|
|
|
|
(1S,5R)-N,N,6,6-Tetramethylbicyclo[3.1.1]heptan-3β-amine oxide
|
|
|
|
(3S,4S,7E,11E)-3-(Methoxymethyl)-4-(methoxycarbonyl)-7,11-dimethylcyclotetradeca-7,11-diene-1-acetic acid methyl ester
|
|
C23H38O5
|
|
(3S,4R)-8-Nonene-3,4-diol
|
|
C9H18O2
|
|
(S,R)-N-(1-Phenylethyl) Ibuprofen AMide
|
81576-47-8
|
C21H27NO
|
|
|
(1S,5R)-N-Phenyl-8-oxabicyclo[3.2.1]oct-6-en-3α-amine
|
|
|
|
|
(1S,4R)-2α-Norbornanecarboxylic acid ethyl ester
|
|
|
|
|
(1S,5R)-N-Phenyl-N-propionyl-8-oxabicyclo[3.2.1]oct-6-en-3α-amine
|
|
|
|
(1S,5R)-N-Phenyl-8-oxabicyclo[3.2.1]oct-6-en-3-imine
|
|
C13H13NO
|
|
(1S,3S,4E)-4-[(2E)-2-[(1R,3aR,7aS)-1-[(E,2S)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-6-methylidene-cyclohexane-1,3-diol
|
87649-67-0
|
C28H44O2
|
|
D-(+)-Norephedrine
|
37577-28-9
|
C9H13NO
|
|
(1S,2S,4E,8E)-2,6,6,9-Tetramethyl-1-nitro-2-nitroso-4,8-cycloundecadiene
|
|
C15H24N2O3
|
|
(1S,4S,7E,11E)-4-[2-(tert-Butyldimethylsiloxy)ethyl]-3-oxo-4,8,12-trimethylcyclotetradeca-7,11-diene-1-carbonitrile
|
|
C26H45NO2Si
|
|
|
S,S'-[(1E,3E)-1,2,3,4-Tetrachloro-1,3-butadiene-1,4-diyl]bis[N1-(carboxymethyl)-N2-(L-γ-glutamyl)-L-cysteinamide]
|
|
|
|
S,S'-[(1E,3E)-1,2,3,4-Tetrachloro-1,3-butadiene-1,4-diyl]bis(N-acetylcysteine)
|
|
C14H16Cl4N2O6S2
|
|
(2S,5S)-9-[(4E)-1-Ethenyl-1,5,9-trimethyl-4,8-decadienyl]-2-isopropyl-1,2,4,5,6,8-hexahydro-5-hydroxymethyl-1-methyl-3H-pyrrolo[4,3,2-gh]-1,4-benzodiazonin-3-one
|
|
C32H47N3O2
|
|
(5S,6S,7E,9E,11Z,14Z)-5,6-Dihydroxy-7,9,11,14-icosatetraenoic acid
|
|
C20H32O4
|
|
4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoic acid
|
72059-45-1
|
C20H30O3
|
|
|
SRn10 protein
|
|
|
|
|
SSDP, vertebrate
|
|
|
|
|
(7S,9S,10E)-4,5,6,7,8,9-Hexahydro-9-acetoxy-3-(acetoxymethyl)-7-hydroxy-10-methyl-6-methylenecyclodeca[b]furan-2(11aαH)-one
|
|
|
|
(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-3-methyl-5,14,16-tris(trimethylsilyloxy)-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
|
72060-12-9
|
|
|
(3S,5S,11E)-3,4,5,6,9,10-Hexahydro-5,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
|
40785-65-7
|
C18H22O6
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-4-benzyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-4-benzyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-4-ethyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-4-ethyl-7,7,8,8-tetramethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-4,7,7,8,8-pentamethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
(1S,6S)-2-(β-D-Ribofuranosyl)-6-fluoro-4,7,7,8,8-pentamethyl-2,4-diazabicyclo[4.2.0]octane-3,5-dione
|
|
|
|
|
1-SS-D-RIBOFURANOSE 1,2,3,5-TETRAACETATE
|
|
|
|
|
Sse9I
|
|
|
|
|
9-[SS-D-RIBOFURANOSYL]-2,6-DIAMINOPURINE
|
|
|
|
[S(R)]-N-[(4S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]-2-methyl-2-propanesulfinamide
|
674767-90-9
|
C20H21Cl2NOS
|
|
(2S,3R)-N-[(3R,4S)-5,8-Dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-2-(dimethylamino)-3-methylpentanamide
|
21761-50-2
|
C27H34N4O4
|
|
(2S,3R)-N-[(3R,4S,7S)-7-Benzoyl-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14(1),15-tetren-4-yl]-2-(dimethylamino)-3-methylpentanamide
|
21761-48-8
|
C34H38N4O5
|
|
(2S,3R)-N-tert-Butoxycarbonyl-3-benzoyloxy-2-pyrrolidinecarboxylic acid methyl ester
|
496841-07-7
|
C18H23NO6
|
|
(2S,3R)-N-(tert-Butyloxycarbonyl)-3-Methyl-5-oxo-pyrrolidinecarboxylic Acid
|
910548-25-3
|
C11H17NO5
|
|
(2S,3R)-N-(tert-Butyloxycarbonyl)-O-(tert-butyl)diMethylsilyl-3,4-dehydro-pyroglutaMinol
|
81658-27-7
|
C16H29NO4Si
|
|
(2S,3R)-N-(tert-Butyloxycarbonyl)-3-Methyl-pyroglutaMinol
|
910548-24-2
|
C11H19NO4
|
|
(4S,5S,E)-5-Hydroxy-4-[(tert-butyldimethylsilyl)oxy]-2-hexenoic acid ethyl ester
|
|
C14H28O4Si
|
|
(4S,5S,E)-5-Hydroxy-4-[[(3,4,5,6-tetrahydro-2H-pyran)-2-yl]oxy]-2-hexenoic acid ethyl ester
|
|
C13H22O5
|
|
(4S,5S)-6-[(E)-1-(Hydroxymethyl)ethylidene]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt
|
|
C11H12NNaO4
|
|
(4S,5S,E)-4-Hydroxy-5-[(tert-butyldimethylsilyl)oxy]-2-hexenoic acid ethyl ester
|
|
C14H28O4Si
|
|
(3S,4R)-N-(TERT-BUTOXYCARBONYL)-4-AMINO-3-HYDROXY-5-PHENYLPENTANOIC ACID
|
|
C16H23NO5
|
|
(3S,4R)-N-(TERT-BUTOXYCARBONYL)-4-AMINO-3-HYDROXY-6-METHYLHEPTANOIC ACID
|
|
C13H25NO5
|
|
(1’S,2R)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl]-6-fluorochroman-4-one
|
797054-21-8
|
C14H15FO4
|
|
Clindamycin
|
18323-44-9
|
C18H33ClN2O5S
|
|
(1S,2R)-N-TOSYLEPHEDRINE
|
127641-25-2
|
C13H19NO
|
|
[[[2S,6R]-6-[N-[Trifluoromethylcarbonyl]-N-[(S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid methyl ester
|
|
C25H27F3N2O6S2
|
|
|
[[(2S,6R)-6-[N-(Trifluoromethylcarbonyl)-N-[(S)-1-(methoxycarbonyl)-3-(2,3,4,5,6-2H5)phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid methyl ester
|
|
|
|
[[[2S,6R]-6-[N-[Trifluoromethylcarbonyl]-N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]hexahydro-5-oxo-2-(2-thienyl)-1,4-thiazepin]-4-yl]acetic acid methyl ester
|
|
C26H29F3N2O6S2
|
|
(S,R)-Palonosetron Hydrochloride
|
135729-76-9
|
C19H25ClN2O
|
|
(2S,6R)-2-Palmitoylamino-6,7-di(palmitoyloxy)heptanoic acid benzyl ester
|
|
C62H111NO7
|
|
(2S,6R)-2-Palmitoylamino-6,7-di(palmitoyloxy)heptanoic acid
|
|
C55H105NO7
|
|
[S,(-)]-2,3'-Selenodipropionic acid
|
|
C6H10O4Se
|
|
[S,(+)]-2-Selenocyanatopropionic acid potassium salt
|
|
C4H4KNO2Se
|
|
[S,(+)]-2-Selenocyanatopropionic acid ethyl ester
|
|
C6H9NO2Se
|
|
|
SrpA protein, Pseudomonas
|
|
|
|
|
(S,S)-Duphos and BPE Rhodium Catalyst Kit for Asymmetric Hydrogenation
|
|
|
|
|
SrpA protein
|
|
|
|
(S,S)-F-BINAPHANE
|
544461-38-3
|
C54H32FeP2
|
|
(S,S)-DUTHALER-HAFNER REAGENT
|
140462-73-3
|
C36H28ClO4Ti
|
|
(2S,3S,4E)-2-Methyl-3-(trimethylsilyl)-4-hexenoic acid
|
|
C10H20O2Si
|
|
(2S,3S,4E)-2-Methoxy-3-(trimethylsilyl)-4-hexenoic acid
|
|
C10H20O3Si
|
|
(2S,3S,4E)-2-Methyl-3-[dimethyl(phenyl)silyl]-6-benzoyloxy-4-hexenoic acid
|
|
C22H26O4Si
|
|
|
SrpB protein
|
|
|
|
3S, 5S enantioMer of Atorvastatin CalciuM
|
1105067-88-6
|
C33H34CaFN2O5+
|
|
s,s-endo-lurasidone HCl
|
1318074-27-9
|
C28H36N4O2S
|
|
|
SrpC protein, Pseudomonas
|
|
|
|
|
SR-PE-ISOCETTE
|
|
|
|
(2S,3R)-3-Pentyloxirane-2-methanol acetate
|
|
C10H18O3
|
|
grayanol B
|
52611-78-6
|
C20H32O6
|
|
|
SS- Fenvalerate
|
|
|
|
2-[(2S,3R)-3-Pentyloxiran-2-yl]ethanol
|
|
C9H18O2
|
|
(2S,8R)-2-Pentyl-8-propyloxocane
|
|
C15H30O
|
|
(2S,3R)-4-Pentene-1,2,3-triol
|
|
C5H10O3
|
|
|
(17S,21S)-17,21-Epidioxy-17,21-epoxy-17,21-secohopane
|
|
|
|
22S,23S-EPICASTASTERONE
|
72050-69-2
|
C28H48O5
|
|
|
S-ropivacaine mesylate
|
|
|
|
|
(S)-ROPIVACAINE MSILATE
|
|
C17H26N2O.CH3SO3H
|
|
22S,23S-EPIBRASSINOLIDE
|
78821-42-8
|
C28H48O6
|
|
22S,23S-EPICASTASTERONE
|
|
C28H48O5
|
|
|
(S)Ropivacaine Mesilate
|
|
C17H26N2O·CH3SO3H
|